Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Vricarve 3.125 Tablet

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Carvedilol (3.125mg)

Overview Vricarve 3.125 Tablet

Cardisure 3.125mg tablets manage hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving cardiac blood flow. Reduced blood pressure also mitigates stroke and myocardial infarction risks. Administer Cardisure 3.125mg with food, following your physician's prescribed dosage and schedule. Consistent use is crucial, regardless of symptom presence or blood pressure readings. Discontinue only under medical supervision to avoid potential complications. Lifestyle modifications—including regular physical activity, weight management, smoking cessation, moderated alcohol consumption, and a low-sodium diet (as directed by your doctor)—complement treatment. While generally well-tolerated, potential side effects such as lightheadedness, cephalalgia, dyspnea, and fatigue may occur. Report persistent or bothersome side effects to your doctor. Prior to commencing treatment, disclose any pre-existing cardiac or renal conditions, and pregnant or lactating individuals should seek medical counsel.

Primary Ingredients of Vricarve 3.125 Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Vricarve 3.125 Tablet

Managing elevated blood pressure | Addressing angina pectoris | Treating congestive heart failure

Major Benefits of Vricarve 3.125 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vricarve 3.125mg tablets should be administered with food.

Common Side effects of Vricarve 3.125 Tablet:

  • Decreased blood pressure
  • Headache
  • Fatigue
  • Dizziness
  • Breathlessness

How to use Vricarve 3.125 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vricarve 3.125 Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Vricarve 3.125 Tablet works:

Vricarve 3.125 mg tablets combine alpha and beta-blocking properties. This dual action reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vricarve 3.125 Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vricarve 3.125 Tablet during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Vricarve 3.125 Tablet safely. Preliminary human studies indicate minimal infant risk associated with this medication.

DrivingDrivingUNSAFE

Taking a 3.125 mg Vricarve tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Vricarve 3.125 mg tablets may be used by patients with kidney disease without altering the prescribed dosage. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised. Routine blood pressure monitoring is recommended to guide potential dosage modifications.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Vricarve 3.125 mg tablets; dosage modification may be necessary. Consult a physician for guidance. Vricarve 3.125 mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Vricarve 3.125 Tablet :

Should you forget a Vricarve 3.125 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vricarve 3.125 Tablet

LabelValue
Chemical Type Carbazole-propanol derivative
Developing Habits No.
Treatment Category Heart
Behavioral Class Alpha-beta blocker

FAQs on Vricarve 3.125 Tablet

Take Vricarve 3.125 tablets regularly as prescribed. Abruptly stopping the medication can lead to chest pain or a heart attack. Your doctor will gradually reduce your dosage before completely discontinuing it, if necessary.
Vricarve 3.125 Tablet may cause tiredness and dizziness, especially at the start of treatment or after a dose increase. Avoid driving or operating machinery if you experience these side effects.
Weight gain is a possible side effect of Vricarve 3.125 Tablet, though not universal. If you're using it for heart failure and experience weight gain or shortness of breath, inform your doctor immediately; these could indicate fluid retention.
Vricarve 3.125 Tablet may rarely worsen kidney function in heart failure patients. However, the risk of kidney failure is increased in patients with low blood pressure (systolic <100 mmHg), arterial hardening, pre-existing heart disease, or impaired kidney function. These patients require close monitoring during treatment. Kidney function typically recovers upon discontinuation of Vricarve 3.125 Tablet.
Diabetic patients may take Vricarve 3.125mg tablets, but regular blood glucose monitoring is crucial. Studies show minimal impact on blood glucose in well-controlled diabetics with mild to moderate hypertension. However, beta-blockers like Vricarve can mask hypoglycemic symptoms, such as increased heart rate. Furthermore, it might worsen hyperglycemia in diabetic patients with heart failure. Therefore, close blood glucose monitoring is essential when starting, adjusting, or stopping Vricarve 3.125mg, and any changes should be reported to a doctor immediately.
Taking Vricarve 3.125 Tablet with food is advised. Food slows absorption, minimizing the risk of orthostatic hypotension (dizziness or fainting upon standing due to low blood pressure).
Vricarve 3.125 Tablet can cause serious side effects including fainting, shortness of breath, weight gain, and swelling in the extremities (arms, hands, feet, ankles, or lower legs). Other possible side effects are chest pain, abnormal heart rhythm, rash, hives, itching, and difficulty breathing or swallowing. Seek immediate medical attention if any of these occur.
Exceeding the recommended Vricarve 3.125 Tablet dosage can cause slowed heart rate, dizziness, fainting, breathing difficulties, vomiting, unconsciousness, or seizures. Seek immediate medical attention at a hospital and contact your doctor.
Vricarve 3.125 Tablet is contraindicated in patients with severe heart failure requiring intensive care or inotropic support, those with asthma or other respiratory issues, bradycardia or arrhythmias, liver impairment, or a known allergy to Vricarve 3.125 Tablet.
Vricarve 3.125 Tablet
32
MRP 37
13% off